Trial Profile
Treatment of adults Ph+ALL with dasatinb in induction and maintenance therathpy followed by allogeneic HSCT: A multicenter, no controll, prospective stduy.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2017
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 14 Mar 2017 New trial record